![]() Biofrontera Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics. | ![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ||
Founding Date | Founding Date 1948 | Founding Date 2012 | Founding Date 2002 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Leverkusen, DE HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | |
Employees | Employees 650 | Employees 91 | Employees 58415% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 m | Valuation ($) 3.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) €13.2m (FY, 2025) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods €2.2m (FY, 2025) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit £510.3m (FY, 2019) | Gross profit €11.2m (FY, 2025) | Gross profit $561.3m (FY, 2025) |
Net income | Net income £88.3m (FY, 2019) | Net income (€6.9m) (FY, 2025) | Net income ($27.1m) (FY, 2025) |

Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
View company
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company